Literature DB >> 1119516

Bilateral recurrent acute retinal pigment epitheliitis.

M W Friedman.   

Abstract

Acute retinal pigment epitheliitis appears to be a specific discrete process of unknown etiology. It is generally unilateral but can be recurrent and can affect both eyes. Eyes in which the disease has run its course exhibit little or no unusual ophthalmoscopic or visual function abnormalities. The actue phase of the disease is localized to the macular area. The lesions are localized in the retinal pigment epithelium as shown by slit-lamp and contact-lens examination, the small lesions more or less surrounding the fovea. They vary from tiny grayish to black spots, which may become surrounded by a lighter halo. Fluroescein angiography is normal in acute phases but the halo-like areas may represent "window defects" with hyperfluorescence in later stages.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1119516     DOI: 10.1016/0002-9394(75)90793-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Foveomacular retinitis.

Authors:  B S Kuming
Journal:  Br J Ophthalmol       Date:  1986-11       Impact factor: 4.638

2.  A case of acute retinal pigment epithelitis: spectral domain optical coherence tomography time course and physiopathologic hypothesis.

Authors:  Nathalie Puche; Olivier Offret; Jean-Antoine Bernard; Francine Behar-Cohen
Journal:  Clin Ophthalmol       Date:  2010-09-20

3.  Macular function and morphology in acute retinal pigment epithelitis.

Authors:  Fatih C Gundogan; Oktay Diner; Ahmet Tas; Abdullah Ilhan; Umit Yolcu
Journal:  Indian J Ophthalmol       Date:  2014-12       Impact factor: 1.848

4.  B-scan and "en-face" spectral-domain optical coherence tomography imaging for the diagnosis and followup of acute retinal pigment epitheliitis.

Authors:  Flore De Bats; Benjamin Wolff; Martine Mauget-Faÿsse; Claire Scemama; Laurent Kodjikian
Journal:  Case Rep Med       Date:  2013-02-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.